Bioprocessing Summit Europe | 19-21 March 2024

Now Accepting Speaker Proposals – Deadline 13 September Submit a Proposal

About Bioprocessing Summit Europe

Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, and analytical professionals from industry and academia to advance the manufacture, quality, and control of next generation biologics and genetic therapies.

This 3-day, 14-track meeting has quickly become a premier event in the European bioprocessing calendar and focuses on the latest innovations in bioprocess R&D as well as the practical solutions to enhance efficiency, speed and cost in biomanufacturing.

New for 2025, we are excited to add a new conference stream on process modelling and digitalization, alongside expanded content on ML/AI, advanced process control, developability, cell culture, downstream processing, analytics, and the latest in cell, gene, and RNA therapies.

2024 PLENARY KEYNOTES

Paul Varley, PhD

What Have Monoclonal Antibodies Ever Done for Us? Past, Present and Future Perspectives on Antibodies and How They Have Driven Bioprocessing Progress

Paul Varley, PhD
SVP, Development, Alchemab Therapeutics

Eva Rohde, M.D.

Extracellular Vesicles as Promising Drug Modalities in Spinal Cord Injury and Other (Neuro-)Degenerative Diseases

Eva Rohde, M.D.
Chair, Transfusion Medicine, Director GMP Unit, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University Salzburg

Highlights from Bioprocessing Summit Europe